GEA-228

N/A

Report date: 2022/01/10 18:08:27
NME

Base Information

Drug NameGEA-228
Drug Alias NameGEA-228
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 5B modulators
TargetsSignal transducer and activator of transcription 5B
Therapy Area/IndicationsMultiple SclerosisArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGenEros Biopharma Hangzhou Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenEros Biopharma Hangzhou Ltd
Inactive CompaniesN/A
Active IndicationsMultiple SclerosisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A